An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check)

Sponsor
World Health Organization (Other)
Overall Status
Recruiting
CT.gov ID
NCT06090006
Collaborator
London School of Hygiene and Tropical Medicine (Other), University of Ghana (Other), Mwanza Intervention Trials Unit (Other), Biomedical Research and Training Institute (Other)
6,000
3
1
16
2000
125

Study Details

Study Description

Brief Summary

This is a multi-country prospective intervention study, with a mixed-method process evaluation to assess the implementation, effects and short-term cost-effectiveness of Y-Check. The intervention involves screening, on-the-spot care and, if needed, referral of adolescents through health and wellbeing check-up visits in early adolescence (10-14 years) and older adolescence (15-19 years old). In each city, the intervention will be delivered to 2000 adolescents recruited in schools (both age groups) or community venues (older adolescents only).

Condition or Disease Intervention/Treatment Phase
  • Other: Screening package
  • Diagnostic Test: Psychosocial and mental health disorder screening
  • Diagnostic Test: Alcohol, tobacco and substance use screening
  • Behavioral: Diet and physical activity screening
  • Diagnostic Test: Underweight and overweight screening
  • Diagnostic Test: Anemia
  • Behavioral: Oral health screening
  • Behavioral: Circumcision screening
  • Behavioral: Risky behaviours
  • Diagnostic Test: HIV testing
  • Diagnostic Test: STI (CT, NG, TV) testing
  • Behavioral: Immunization screening
  • Diagnostic Test: Visual impairment screening
  • Diagnostic Test: Hearing screening
  • Diagnostic Test: Physical impairment screening
  • Diagnostic Test: Uncontrolled epilepsy screening
  • Diagnostic Test: Pre-hypertension screening
N/A

Detailed Description

Background: During adolescence, behaviours are initiated that will have substantial positive or negative impacts on the individual's short- and long-term health and wellbeing, educational attainment and employment prospects. However, adolescents rarely have regular contact with health services, especially for health promotion and disease prevention, and services are not always appropriate for their needs. The investigators co-developed with adolescents a health and wellbeing check-up programme, to improve adolescent health and wellbeing (Y-Check). This paper describes the methods to evaluate the feasibility, acceptability, short-term effects, and cost-effectiveness of Y-Check in three African cities: Cape Coast in Ghana, Mwanza in Tanzania and Chitungwiza in Zimbabwe.

Method: This is a multi-country prospective intervention study, with a mixed-method process evaluation to assess the implementation, effects and short-term cost-effectiveness of Y-Check. The intervention involves screening, on-the-spot care and, if needed, referral of adolescents through health and wellbeing check-up visits in early adolescence (10-14 years) and older adolescence (15-19 years old). In each city, the intervention will be delivered to 2000 adolescents recruited in schools (both age groups) or community venues (older adolescents only). The adolescents will be followed-up at 4 months (all sites) and 12 months (Zimbabwe only). The study will assess the effects of Y-Check on knowledge and behaviours, as well as clinical outcomes and costs. The primary outcome will be the proportion of those screening positive for at least one condition who receive appropriate on-the-spot care or complete appropriate referral for all identified conditions within four months. Secondary outcomes include yield of untreated conditions, reported health-related risk and protective behaviours, engagement with health services, wellbeing, clinical and educational outcomes. A process evaluation will understand acceptability, feasibility, uptake, and fidelity, and an economic evaluation will explore cost effectiveness.

Discussion: This study is innovative in evaluating a comprehensive adolescent health and wellbeing check-up intervention which addresses both health conditions that impact on wellbeing during adolescence, and risk factors for non-communicable diseases in three African cities. Evidence of the intervention´s feasibility, acceptability, and short-term positive effects and costs will support larger scale intervention implementation and rigorous evaluation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
6000 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
In our study sites, a contemporaneous comparison group is not required since no routine screening is currently taking place, and as a result, assessments at baseline will serve as the counterfactual for internal comparisonsIn our study sites, a contemporaneous comparison group is not required since no routine screening is currently taking place, and as a result, assessments at baseline will serve as the counterfactual for internal comparisons
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check): Protocol for a Multimethod, Prospective, Hybrid Implementation-effectiveness Study
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: No comparison group

In our study sites, a contemporaneous comparison group is not required since no routine screening is currently taking place, and as a result, assessments at baseline will serve as the counterfactual for internal comparisons

Other: Screening package
Y-Check is a novel intervention delivering a health check-up and where indicated will provide on-the-spot care and referral for common conditions on two occasions in adolescence (in young adolescents (10-14 year-olds) - soon after the onset of puberty - and again in older adolescents (15-19 year-olds) - when many adolescents become, or are soon to become, sexually active). It will also provide health promotion information and materials to support positive behaviours and healthy lifestyles during adolescence and beyond. Adolescents will only be screened for conditions that have an accurate, low-cost, acceptable screening test and a locally accessible, effective intervention. The conditions selected for screening will be chosen to reflect the local epidemiological contexts (e.g. screening for malaria will only take place in high malaria endemic areas).
Other Names:
  • Check ups
  • Diagnostic Test: Psychosocial and mental health disorder screening
    HEEADSSS stands for Home, Education/Employment, Eating, Activities, Drugs, Sexuality, Suicide/Depression, and Safety (Klein et al., 2014) and Patients´ Health Questionnaire - Adolescent (PHQ-A), Generalised Anxiety Disorder (GAD-9) and counselling and referral where indicated

    Diagnostic Test: Alcohol, tobacco and substance use screening
    World Health Organization (WHO) ASSIST-Y tool (Humeniuk, 2016) and referral where indicated

    Behavioral: Diet and physical activity screening
    HEEADSSS (Klein et al., 2014) and counselling and advice

    Diagnostic Test: Underweight and overweight screening
    MUAC (Middle Upper Arm Circumference), BMI (Body Mass Index) followed by Counselling and advice +/- referral where indicated

    Diagnostic Test: Anemia
    Hemocue. Iron and folic-acid supplementation (3 months supply) if anaemic. If severely anaemic (<8g/dl) refer to health facility.

    Behavioral: Oral health screening
    Questions on oral health and visual inspection followed by advice, gift of toothpaste and toothbrush, fluoride varnish application +/- Silver Diamine Fluoride application +/- referral

    Behavioral: Circumcision screening
    Question on circumcision status. Visual inspection. Referral for Voluntary Medical Male Circumcision) where uncircumcised (males only)

    Behavioral: Risky behaviours
    Question (s) on sexual activity and other risky behaviours, followed by Risk reduction counselling, Provision of condoms, Provision of modern contraceptives (emergency contraception, depot injections, oral contraceptive pill) (females only) PreExposure Prophylaxis (PrEP) (females only)

    Diagnostic Test: HIV testing
    HIV oral mucosal self-test +/- confirmatory blood-based rapid diagnostic test followed by Counselling + referral to treatment where indicated

    Diagnostic Test: STI (CT, NG, TV) testing
    Chlamydia Trachomatic (CT) /Neisseria Gonorrhea (NG) test on urine sample, Trichomoniasis Vaginalis (TV) test and treatment where indicated

    Behavioral: Immunization screening
    Question on Human Papilloma Virus (HPV) immunisation history. Review of vaccination card. Followed by referral to immunization

    Diagnostic Test: Visual impairment screening
    Peek Acuity or Snellen Tumbling-E and Refer to specialist if indicated

    Diagnostic Test: Hearing screening
    HearScreen smartphone app +/- HearTest plus Inspection for presence of wax and wax removal. Refer to specialist if indicated

    Diagnostic Test: Physical impairment screening
    Questions on physical impairment. Jump or squat test Functional reach test Referral to specialist if indicated

    Diagnostic Test: Uncontrolled epilepsy screening
    Questions on experience of convulsions followed by referral to specialist if indicated

    Diagnostic Test: Pre-hypertension screening
    Blood pressure measured using digital sphygmomanometer followed by counselling and advice if indicated

    Outcome Measures

    Primary Outcome Measures

    1. Y-Check Screening outcome [16 weeks (4 months)]

      Proportion of those screening positive for at least one condition who receive appropriate on-the-spot care or complete appropriate referral for all identified conditions within 4 months (i.e. they attend a provider for referral care who has been accredited by the study team and has been shown to be capable of providing appropriate referral care).

    Secondary Outcome Measures

    1. Condition Screening outcome [16 weeks (4 months)]

      Proportion of those screening positive for each condition who receive appropriate on-the-spot care or complete appropriate referral for that condition within 4 months.

    2. Previously untreated conditions identified (yield) [16 weeks (4 months)]

      This will be measured as: Numerator: number of individuals identified with a condition that is not currently being treated and requires counselling and/or treatment Denominator: number of individuals who were screened for the condition.

    3. Qualitative assessment of adolescents who find the intervention acceptable [16 weeks (4 months)]

      Qualitative assessment tool for acceptability of adolescent wellbeing interventions

    4. Qualitative assessment of teachers, parents and health workers who find the intervention acceptable [16 weeks (4 months)]

      Qualitative assessment tool for acceptability of adolescent wellbeing interventions

    5. Proportion of adolescents who take up and use Y-Check services and referrals [16 weeks (4 months)]

      Proportion of young people invited who complete the screening program; proportion of young people invited who complete referrals. Qualitative assessment tool will also be used to assess intervention adoption

    6. Qualitative assessment of perceived value of the intervention to adolescents and to other stakeholders. [16 weeks (4 months)]

      Intervention appropriateness (perceived fit, perceived relevance, perceived usefulness): perceived value of the intervention to adolescents and to other stakeholders.

    7. Proportion of Y-Check visits completed [16 weeks (4 months)]

      Intervention feasibility (actual fit, practicability): Y-Check visits completed

    8. Proportion of referrals completed [16 weeks (4 months)]

      Intervention feasibility (actual fit, practicability): Referrals completed

    9. Proportion of youth reporting youth friendly health services received with quality [16 weeks (4 months)]

      youth-friendly health services quality assessment.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 19 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    To be included in the study, adolescents aged 10-19 must fall into one of the first three categories below and fulfil category 4.

    1. Be attending selected classes of Year 5 of primary school in Mwanza (median age 11 years); Grade 5/6 of primary school in Chitungwiza (median age 11 years); or Year 1 of Junior Secondary School in Cape Coast (median age 12 years) OR

    2. Be attending selected classes in Year 3 of Secondary School in Mwanza (median age 17 years), Form 3/4 in Chitungwiza (median age 17 years), or Year 2 of Senior Secondary School in Cape Coast (median age 16 years) OR

    3. Be resident in a selected community during the time of the Y-Check intervention, and be aged 16-19 years AND

    4. Have a completed and signed Informed Consent and have a signed Informed Assent Form if the adolescent is below the national age of consent or is seen in a school, irrespective of their age.

    Exclusion Criteria:

    Not meeting above inclusion criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Schools and Community Centers Cape Coast Ghana
    2 Schools and community centers Mwanza Tanzania
    3 Schools and community centers Chitungwiza Zimbabwe

    Sponsors and Collaborators

    • World Health Organization
    • London School of Hygiene and Tropical Medicine
    • University of Ghana
    • Mwanza Intervention Trials Unit
    • Biomedical Research and Training Institute

    Investigators

    • Principal Investigator: Prerna Banati, PhD, World Health Organization
    • Principal Investigator: Baltag Valentina, MD, World Health Organization
    • Principal Investigator: Aoife Doyl, PhD, Biomedical Training and Research Institute
    • Principal Investigator: Saidi Kapiga, MD, Mwanza Intervention Trials Unit
    • Principal Investigator: Benedict Weobong, PhD, University of Ghana

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Prerna Banati, Scientist, Principal Investigator, World Health Organization
    ClinicalTrials.gov Identifier:
    NCT06090006
    Other Study ID Numbers:
    • WHO ERC.0003778
    First Posted:
    Oct 19, 2023
    Last Update Posted:
    Oct 19, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Oct 19, 2023